Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sinovac Biotech Ltd.

http://www.sinovac.com/

Latest From Sinovac Biotech Ltd.

Rapid Response, No Ultracold: China Sees Global Opening For Vaccine Supplies

SinoVac’s rapid antibody response, CanSino’s easier logistics requirements - plus cost advantages - make Chinese developers optimistic about supplying the world with COVID vaccines.

China Coronavirus COVID-19

Coronavirus Update: Moderna Ready For Interim Analysis, Brazil Resumes SinoVac Trial

Moderna's vaccine has reached the requisite number of cases to trigger a Phase III interim analysis and Brazil allows SinoVac's trial to resume after a serious adverse event, but AstraZeneca's Calquence fails to show any benefit in hospitalized COVID-19 patients. Medicago and GSK also report vaccine progress and the RDIF strikes another production deal.

Coronavirus COVID-19 Clinical Trials

Brazil Halts SinoVac COVID Vaccine Trial As China Lead Erodes

China’s race to the coronavirus vaccine finish line has been dimmed by a new setback, although CanSino has commenced dosing of patients in Mexico and $328m in funding will help propel Clover's protein-based contender to the final stage.

Coronavirus COVID-19 Research & Development

Coronavirus Vaccines As A Public Good: How Reasonable Is Reasonable?

During a recent press briefing, health officials in China disclosed the country is poised to reach an annual production capacity of 610 million doses for coronavirus vaccines. But they said prices must be based on manufacturing costs and not driven by supply and demand.

Coronavirus COVID-19 Vaccines
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
    • Drug Delivery
    • Vaccines
  • Medical Devices
    • Implantable Devices
    • Monitoring Equipment & Devices
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Other Names / Subsidiaries
    • Beijing Kexing Bioproducts
    • Sinovac Dalian Vaccine Technology Co., Ltd.
    • Sinovac (Cayman) Limited
UsernamePublicRestriction

Register